Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. C. Keen
The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-Regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine Kinase
Cancer Research
Cancer Research
Oncology
Related publications
HuR Regulates -Tubulin Isotype Expression in Ovarian Cancer
Cancer Research
Cancer Research
Oncology
RNA Binding Protein HuR Regulates the Expression of ABCA1
Journal of Lipid Research
Biochemistry
Endocrinology
Cell Biology
The Role of GLI-SOX2 Signaling Axis for Gemcitabine Resistance in Pancreatic Cancer
Oncogene
Cancer Research
Genetics
Molecular Biology
Establishment and Characterization of the Gemcitabine‑resistant Human Pancreatic Cancer Cell Line SW1990/gemcitabine
Oncology Letters
Cancer Research
Oncology
GPRC5A Is a Potential Oncogene in Pancreatic Ductal Adenocarcinoma Cells That Is Upregulated by Gemcitabine With Help From HuR
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Fasting Cycles Potentiate the Efficacy of Gemcitabine Treatment in in Vitro and in Vivo Pancreatic Cancer Models
Oncotarget
Oncology
Timing of Chemotherapy-Induced Neutropenia: The Prognostic Factor in Advanced Pancreatic Cancer Patients Treated With Gemcitabine / Gemcitabine-Based Chemotherapy
Oncotarget
Oncology
Effects of P-Mapa Associated With Gemcitabine in the Pancreatic Cancer: Histologic Effects
Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
